|
|
| (11) | Number of the document | C 2250279 |
| (68) | Number of the document | 2250279 |
| (21) | Application number for Supplementary Protection Certificate | PA 2022 514 |
| (22) | Date of filing the application | 2022-06-27 |
| (41) | Date of publication of the application | 2022-07-25 |
| Date of publication of SPC | 2024-12-10 | |
| (24) | Date of coming into effect of SPC | 2029-02-07 |
| (71) |
AstraZeneca AB,
151 85 Södertälje,
SE
|
| (73) |
AstraZeneca AB,
151 85 Södertälje,
SE
|
| (74) |
Liudmila GERASIMOVIČ,
IĮ "Liudmila Gerasimovič, Patentinis patikėtinis", Vingrių g. 13-42, LT-01141 Vilnius,
LT
|
| (93) | 1/21/1623, 2022-02-15 |
| (94) | 2034-02-06 |
| (95) | Anifrolumabas |
| SPC granted |